Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
Clinical trial NCT02843945 · RECRUITING
Trial details
- NCT number
- NCT02843945
- Sponsor
- CivaTech Oncology
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-31
- Primary completion
- 2027-10-29
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.